Shares of Cerner Corp CERN gained momentum on a potential takeover by Oracle Corp ORCL, Bloomberg reports.
- The possible acquisition of the medical-records company marked the software maker's push into health care.
- Cerner, headed by former Alphabet Inc's GOOG GOOGL Google Health's David Feinberg generated $5.51 billion in revenue during 2020, and its sales will likely rise by 5% to $5.8 billion in 2021.
- Cerner competes with Epic Systems Corp and Allscripts Healthcare Solutions Inc MDRX.
- Cerner could serve as an attractive target for Oracle, the second-biggest software maker by revenue.
- While Oracle has struggled to gain ground in the cloud-computing business, trailing far behind Amazon.com Inc AMZN and Microsoft Corp MSFT, a deal for Cerner would give Oracle a massive foothold in the health industry.
- Price Action: CERN shares traded higher by 19.1% at $94.71 in the premarket session on the last check Friday.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in